Bafna Pharmaceuticals launches new products Afenac, Nocaf, Izabof in domestic market

Bafna Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 532989 | NSE: BAFNAPHARM

Bafna Pharmaceuticals, a Chennai-based Pharma company, has launched Afenac-P Tablets, Afenac TH Tablets, Nocaf Syrup, Izabof Suspension, Izabof-250 86 500 mg Tablets in domestic market. By launching these new products, the company has expanded its base into Pain Management & Anti-infectives.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Date: 25-11-2013
How do you find the content? Rate it now
YOUR RATING
1
2
3
4
5
 
Poor
 
Average
 
Good
 
Very Good
 
Excellent

Avg. user rating based
on 0 votes
0
Have a stock in mind?
X-RAY it First!
Here's the complete List of : BSE 30 | BSE 100 | BSE 200 | BSE 500 | NIFTY 50 | NSE 100 | NSE 200 | NSE 500 Stocks
33.55 -0.45 (-1.32%)
Sep 19, 16:44
Return to Top
Request a Call Back
We will guide you on how to find
the Right stocks at the Right prices.
Mobile
Invalid Mobile Number
x
Thank you for
contacting us.
We will call you
shortly.